首页 › 股票 › BDRX

BDRX — BIODEXA PHARMACEUTICALS PLC

申报持仓市值$524.91K
持有基金数(最新)24
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)8
机构持仓市值$48.06K · 16.57K 股
新建/增持/减仓/清仓1 / 1 / 6 / 1 · 更新于 2026-11-13
前五大/前十大集中度99.9% / 100.0%
机构整体持仓变动 减持 -85.6% (-95.55K 股)
机构持仓市值变动 下降 -32.2%

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 8 家机构在其最新 13F 申报中持有 BDRX(BIODEXA PHARMACEUTICALS PLC),合计申报市值 $48.06K,对应 16.57K 股。按股数计算较上季度减持 85.6%(-95.55K 股),申报市值环比下降 32.2%。持仓集中度较高:前五大持有人占申报市值的 99.9%,前十大的集中度为 100.0%。

与上一季度相比,1 家新建仓位、1 家加仓、6 家减仓、1 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

BIODEXA PHARMACEUTICALS PLC(BDRX)的主要机构持有人包括 SABBY MANAGEMENT, LLC、BOOTHBAY FUND MANAGEMENT, LLC、HRT FINANCIAL LP,按 13F 申报市值在本页 24 家持有人中排名居前。

BDRX 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 6 85.56K $55.56K +2961.0%
Q2 2026 8 16.57K $48.06K -85.6%
Q1 2026 8 369.10K $228.07K +25.3%
Q4 2025 8 305.27K $692.95K -52.3%
Q3 2025 4 8.40K $55.84K -57.3%
Q2 2025 4 19.67K $17.01K -4.4%
Q1 2025 6 21.31K $28.13K +165.0%
Q4 2024 4 7.24K $29.33K -97.2%

表内 8 个季度中,机构持股合计增加 1081%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2025(+165.0%)。

前 25 大机构持仓人(Q3 2026) — 6 家基金

基金股数金额组合权重变化
HRT FINANCIAL LP 71.25K $46.00K 0.00% 新进
StoneX Group Inc. 12.50K $8.37K 0.00% 新进
UBS Group AG 1.79K $1.17K 0.00% 增持
SBI Securities Co., Ltd. 19 $12 0.00% 减持
Caitong International Asset Management Co., Ltd 1 $1 0.00% 减持
JPMorgan Chase & Co 1 $1 0.00% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 8 家基金

基金股数金额组合权重变化
ARMISTICE CAPITAL, LLC 14.81K $43.09K 0.00% 减持
GAMMA Investing LLC 1.20K $3.50K 0.00% 减持
Allied Private Wealth LLC 489 $1.27K 0.00% 新进
SBI Securities Co., Ltd. 29 $84 0.00% 减持
UBS Group AG 25 $73 0.00% 减持
Hilton Head Capital Partners, LLC 6 $17 0.00% 减持
Caitong International Asset Management Co., Ltd 5 $15 0.00% 增持
RHUMBLINE ADVISERS 3 $8 0.00% 减持

Q1 2026 — 8 家基金

基金股数金额组合权重变化
SABBY MANAGEMENT, LLC 257.47K $159.09K 1.86% 增持
ARMISTICE CAPITAL, LLC 97.52K $60.26K 0.00% 减持
GAMMA Investing LLC 13.78K $8.52K 0.00% 增持
SBI Securities Co., Ltd. 151 $93 0.00% 增持
UBS Group AG 127 $78 0.00% 减持
Hilton Head Capital Partners, LLC 30 $19 0.00% 持有
RHUMBLINE ADVISERS 19 $11 0.00% 减持
Caitong International Asset Management Co., Ltd 1 $1 0.00% 新进

Q4 2025 — 8 家基金

基金股数金额组合权重变化
SABBY MANAGEMENT, LLC 190.66K $432.79K 3.17% 新进
ARMISTICE CAPITAL, LLC 100.00K $227.00K 0.00% 新进
HRT FINANCIAL LP 10.58K $24.00K 0.00% 新进
UBS Group AG 2.10K $4.77K 0.00% 减持
GAMMA Investing LLC 1.78K $4.03K 0.00% 增持
SBI Securities Co., Ltd. 101 $229 0.00% 减持
Hilton Head Capital Partners, LLC 30 $68 0.00% 新进
RHUMBLINE ADVISERS 24 $54 0.00% 增持

Q3 2025 — 4 家基金

基金股数金额组合权重变化
UBS Group AG 6.92K $46.05K 0.00% 增持
GAMMA Investing LLC 1.35K $8.99K 0.00% 减持
SBI Securities Co., Ltd. 115 $765 0.00% 减持
RHUMBLINE ADVISERS 5 $32 0.00% 减持

Q2 2025 — 4 家基金

基金股数金额组合权重变化
GAMMA Investing LLC 11.94K $10.33K 0.00% 增持
SBI Securities Co., Ltd. 5.67K $4.90K 0.00% 增持
UBS Group AG 1.99K $1.72K 0.00% 减持
RHUMBLINE ADVISERS 69 $59 0.00% 减持

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q1 2023
HRT FINANCIAL LP 71.25K — — 10.58K — — — — — — — — — —
StoneX Group Inc. 12.50K — — — — — — — — — — — — —
UBS Group AG 1.79K 25 127 2.10K 6.92K 1.99K 18.83K 7.05K 255.45K 10.00K 2.44K 600 71 —
SBI Securities Co., Ltd. 19 29 151 101 115 5.67K 1 1 — — — — — —
Caitong International Asset Management Co., Ltd 1 5 1 — — — — — — — — — — —
JPMorgan Chase & Co 1 — — — — — — — — — — — — —
SABBY MANAGEMENT, LLC — — 257.47K 190.66K — — — — — — — — — —
ARMISTICE CAPITAL, LLC — 14.81K 97.52K 100.00K — — — — — — — — — —
BOOTHBAY FUND MANAGEMENT, LLC — — — — — — — — — — — 44.59K — —
SUSQUEHANNA INTERNATIONAL GROUP, LLP — — — — — — — — — 30.11K — — 11.74K —
Virtu Financial LLC — — — — — — — — — 35.78K — — — —
Renaissance Technologies — — — — — — — — — — — 11.70K — 53.02K
Citadel Advisors — — — — — — — — — 33.44K — — — —
TWO SIGMA SECURITIES, LLC — — — — — — — — 32.58K 20.56K — — — —
GAMMA Investing LLC — 1.20K 13.78K 1.78K 1.35K 11.94K 1.43K — 287 3.89K 11.10K 1.04K — —
Bank of America Corp — — — — — — — — — 859 5.24K 5.24K — —
Ground Swell Capital, LLC — — — — — — — — — 13.08K — — — —
Morgan Stanley — — — — — — 700 — 14.32K 16 16 16 16 —
RHUMBLINE ADVISERS — 3 19 24 5 69 315 154 6.04K 2.71K 498 498 223 —
Allied Private Wealth LLC — 489 — — — — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold BDRX?

As of 2026-Q2, 8 institutional funds reported holding BDRX (BIODEXA PHARMACEUTICALS PLC) in SEC 13F filings, with a combined reported value of $48.06K.

How many shares of BDRX do institutions own?

13F filers reported 16.57K shares of BDRX, worth $48.06K in aggregate at the end of 2026-Q2.

Is institutional ownership of BDRX rising or falling?

Share counts moved -85.6% versus the prior quarter — distribution.

Who are the top institutional holders of BDRX?

The largest 13F holders are SABBY MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, HRT FINANCIAL LP, ARMISTICE CAPITAL, LLC, Virtu Financial LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of BIODEXA PHARMACEUTICALS PLC?

The major shareholders of BIODEXA PHARMACEUTICALS PLC (BDRX) by reported 13F value are SABBY MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, HRT FINANCIAL LP, ARMISTICE CAPITAL, LLC, Virtu Financial LLC, among 24 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 BDRX」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/BDRX/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →